Muscular Atrophy, Spinal, Type III: Clinical Trials

1 trial for Muscular Atrophy, Spinal, Type III, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Unknown 1

Follow Muscular Atrophy, Spinal, Type III: new trials by email Literature Review of Muscular Atrophy, Spinal, Type III trials Research Report on Muscular Atrophy, Spinal, Type III

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Home Monitoring of Adult Patients With SMA: a Pilot Multicenter Validation Study
Strength force measurment, Time tests, Motor scales - Muscular Atrophy, Spinal, Type II, Muscular Atrophy, Spinal, Type III
Not applicableUnknownInstitut de Myologie, France602023-12-152023-12-01

Narrower conditions

Muscular Atrophy, Spinal (1)  ·  Spinal Muscular Atrophies of Childhood (1)

Broader conditions

Central Nervous System Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Heredodegenerative Disorders, Nervous System (1)  ·  Motor Neuron Disease (1)  ·  Nervous System Diseases (1)  ·  Neurodegenerative Diseases (1)  ·  Neuromuscular Diseases (1)  ·  Spinal Cord Diseases (1)

Interventions

Accelerometry (1)  ·  Bleeding Time (1)  ·  LIMS1 protein, human (1)  ·  Surveys and Questionnaires (1)

Sponsors

Institut de Myologie, France (1)

Countries

France (1)